Marijuana of America : Announces Completion of Regulation A Offering; Commencement of Registered Offering - Form 8-K
August 16, 2022 at 09:24 pm
Share
Marijuana Company of America, Inc. Announces Completion of Regulation A Offering; Commencement of Registered Offering
Tuesday, August 17, 2022, 6:00 PM
LOS ANGELES, CA / ACCESSWIRE / August 16, 2022 / Marijuana Company of America, Inc. (OTC PINK:MCOA) ("the Company" or "MCOA"), a diversified holding company with operations and investments throughout the cannabis industry, today announced the termination of the Company's current Regulation A offering and the effective registration of its new Equity Financing Facility that was signed on May 31, 2022. The Company expects to use the Equity Financing Facility funding to execute its growth initiatives and to fulfill future projects.
"As of today, MCOA terminates its Regulation A common stock offering originally qualified by the SEC on October 20, 2021", said Jesus M. Quintero, CEO of MCOA. "The S-1 for our new equity purchase facility, filed on July 14 this summer, was declared effective on July 28. Moving forward, the Company will source growth capital for the expansion of our CBD distribution revenue through the equity purchase facility."
Attachments
Original Link
Original Document
Permalink
Disclaimer
Marijuana Company of America Inc. published this content on 16 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 August 2022 20:23:01 UTC.
Marijuana Company of America, Inc. is an owner and operator of licensed cannabis cultivation, processing, and dispensary facilities. The Company is a developer, producer, and distributor of branded cannabis and cannabidiol (CBD) products in the United States. Through its wholly owned subsidiary cDistro, Inc., it offers CBD brands along with smoke and vape shop-related products to wholesalers, c-stores, specialty retailers, and consumers in North America. Through its wholly owned subsidiary HSmart, Inc., it develops and sells CBD products under the brand name hempSMART. Its hempSMART wellness products offerings include hempSMART Brain, hempSMART Pain, hempSMART Pain Cream, hempSMART Drops, hempSMART Pet Drops, hempSMART Face, and hempSMART Drink Mix. hempSMART Brain is a personal care consumer product encapsulated with enriched non-psychoactive industrial hemp derived CBD. hempSMART Pain Cream each container is formulated with 300mg of non-psychoactive CBD.